1-7 of 7
J. Diaz Mediavilla
Close
Sort by
Journal Articles

Treatment of Diffuse Large B Cell Lymphoma with CHOP and Rituximab. Results of a Multicenter Study with 236 Patients.

Javier De la Serna, R. Ayala, M. Canales, P. Giraldo, M. de la Cruz-Mora, A. Rueda, C. Montalban, J. Queizan, J. Garcia-Vela, F. Feliu, C. Calle, B. Hernandez, R. Hernandez, F. Solano, J. Peñalver, J. Ojanguren, J. Sanchez-Guilarte, C. Morante, C. Nicolas, A. Roman, L. Palomera, J. Diaz-Mediavilla
Journal: Blood
Blood (2005) 106 (11): 4736.
https://doi.org/10.1182/blood.V106.11.4736.4736
Published: 2005
Journal Articles

High-Dose Therapy/Stem Cell Support (HDT), Including Tandem Transplant, for Primary Refractory Multiple Myeloma (MM): Results from the Spanish Myeloma Group (PETHEMA/GEM) in 49 Patients.

L. Rosinol, R. Garcia-Sanz, J. J. Lahuerta, M. Hernandez-Garcia, A. Sureda, J. de la Rubia, J. M. Ribera, B. Hernandez-Ruiz, D. Carreras, I. Navarro, J. C. Garcia-Ruiz, S. Gardella, J. Garcia-Larana, J. Diaz-Mediavilla, J. F. San Miguel, J. Blade
Journal: Blood
Blood (2005) 106 (11): 5472.
https://doi.org/10.1182/blood.V106.11.5472.5472
Published: 2005
Journal Articles

Re-Treatment with Rituximab Plus Chemotherapy in Patients with Diffuse Large-B Cell Lymphoma (DLBCL): A Spanish Multicenter Study.

Miguel A. Canales, A. Palacios, C. Martinez-Chamorro, M. A. Cruz, J. M. Moraleda, M. J. Terol, M. Almagro, J. A. Garcia-Vela, D. Aguiar, D. Caballero, J. M. Sancho, S. Ferrer, A. Rueda, J. M. Calvo, J. A. Fernandez, J. Diaz-Mediavilla, J. Gonzalez, J. Mayans, C. Montesinos, E. Rios, A. Ruedas, P. Sabin, A. Fernandez-Jurado
Journal: Blood
Blood (2005) 106 (11): 2457.
https://doi.org/10.1182/blood.V106.11.2457.2457
Published: 2005
Journal Articles

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma.

G. Mateo, PhD, M. Castellanos, A. Rasillo, N. C. Gutierrez, MDPhD, M. A. Montalban, M. L. Martin, J. M. Hernandez, MDPhD, M. C. Lopez-Berges, MDPhD, L. Monteiano, Joan Blade, MDPhD, M. V. Mateos, MDPhD, A. Sureda, MDPhD, J. Rubia, MD, J. Diaz-Mediavilla, MDPhD, J. J. Lahuerta, MD, A. Orfao, MDPhD, J.F. San Miguel, MDPhD
Journal: Blood
Blood (2004) 104 (11): 1425.
https://doi.org/10.1182/blood.V104.11.1425.1425
Published: 2004
Journal Articles

A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.

M.V. Mateos, Joan Blade, J. Diaz Mediavilla, J.J. Lahuerta, M.J. Terol, J. Hernández, M.J. Moro, J. Bargay, J.M. Ribera, J. de la Rubia, A. Sureda, D. Carrera, F. de Arriba, L. Palomera, M. Hernández, J. García Laraña, A. Alegre, F. Prosper, P. Rivas, D.L. Esseltine, D. Schenkein, J.F. San Miguel
Journal: Blood
Blood (2004) 104 (11): 3462.
https://doi.org/10.1182/blood.V104.11.3462.3462
Published: 2004
Journal Articles

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

J.F. San Miguel, A. Martı́nez, A. Macedo, M.B. Vidriales, C. López-Berges, M. González, D. Caballero, M.A. Garcı́a-Marcos, F. Ramos, J. Fernández-Calvo, M.J. Calmuntia, J. Diaz-Mediavilla, A. Orfao
Journal: Blood
Blood (1997) 90 (6): 2465–2470.
https://doi.org/10.1182/blood.V90.6.2465
Published: 1997
Journal Articles

Presenting features and prognosis of chronic lymphocytic leukemia in younger adults [see comments]

E Montserrat, F Gomis, T Vallespi, A Rios, A Romero, J Soler, A Alcala, M Morey, C Ferran, J Diaz-Mediavilla
Journal: Blood
Blood (1991) 78 (6): 1545–1551.
https://doi.org/10.1182/blood.V78.6.1545.1545
Published: 1991